NO20063650L - 4-aryl-piperidiner - Google Patents
4-aryl-piperidinerInfo
- Publication number
- NO20063650L NO20063650L NO20063650A NO20063650A NO20063650L NO 20063650 L NO20063650 L NO 20063650L NO 20063650 A NO20063650 A NO 20063650A NO 20063650 A NO20063650 A NO 20063650A NO 20063650 L NO20063650 L NO 20063650L
- Authority
- NO
- Norway
- Prior art keywords
- subject
- compound
- provides
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/757,962 US20050154020A1 (en) | 2004-01-14 | 2004-01-14 | 4-Aryl piperidines |
PCT/US2005/001131 WO2005069834A2 (fr) | 2004-01-14 | 2005-01-13 | 4-aryle piperidines |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063650L true NO20063650L (no) | 2006-08-11 |
Family
ID=34740114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063650A NO20063650L (no) | 2004-01-14 | 2006-08-11 | 4-aryl-piperidiner |
Country Status (15)
Country | Link |
---|---|
US (1) | US20050154020A1 (fr) |
EP (1) | EP1708704A4 (fr) |
JP (1) | JP2007517906A (fr) |
KR (1) | KR20060125825A (fr) |
CN (1) | CN1909904A (fr) |
AR (1) | AR047087A1 (fr) |
AU (1) | AU2005206873A1 (fr) |
BR (1) | BRPI0506814A (fr) |
CA (1) | CA2552362A1 (fr) |
EA (1) | EA011029B1 (fr) |
IL (1) | IL176791A0 (fr) |
MX (1) | MXPA06007660A (fr) |
NO (1) | NO20063650L (fr) |
UA (1) | UA85575C2 (fr) |
WO (1) | WO2005069834A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050154022A1 (en) * | 2004-01-14 | 2005-07-14 | H. Lundbeck A/S | 4-aryl piperidines |
US20090048258A1 (en) * | 2005-02-01 | 2009-02-19 | Masaki Ogino | Amide Compound |
KR100893394B1 (ko) * | 2007-05-11 | 2009-04-17 | 한국화학연구원 | 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물 |
EP2583965B1 (fr) | 2010-07-15 | 2017-01-25 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique |
GB201419976D0 (en) * | 2014-11-10 | 2014-12-24 | Univ Newcastle | Biomarkers for disease progression in melanoma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
US5382583A (en) * | 1989-04-22 | 1995-01-17 | John Wyeth & Brother, Limited | Piperazine derivatives |
US6326381B1 (en) * | 1998-12-17 | 2001-12-04 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates |
UA77536C2 (en) * | 2002-07-03 | 2006-12-15 | Lundbeck & Co As H | Secondary aminoaniline piperidines as mch1 antagonists and their use |
-
2004
- 2004-01-14 US US10/757,962 patent/US20050154020A1/en not_active Abandoned
-
2005
- 2005-01-06 AR ARP050100036A patent/AR047087A1/es not_active Application Discontinuation
- 2005-01-13 CA CA002552362A patent/CA2552362A1/fr not_active Abandoned
- 2005-01-13 WO PCT/US2005/001131 patent/WO2005069834A2/fr active Application Filing
- 2005-01-13 BR BRPI0506814-2A patent/BRPI0506814A/pt not_active IP Right Cessation
- 2005-01-13 MX MXPA06007660A patent/MXPA06007660A/es unknown
- 2005-01-13 CN CNA200580002257XA patent/CN1909904A/zh active Pending
- 2005-01-13 AU AU2005206873A patent/AU2005206873A1/en not_active Abandoned
- 2005-01-13 UA UAA200608045A patent/UA85575C2/ru unknown
- 2005-01-13 KR KR1020067013180A patent/KR20060125825A/ko not_active Application Discontinuation
- 2005-01-13 EA EA200601315A patent/EA011029B1/ru not_active IP Right Cessation
- 2005-01-13 JP JP2006549604A patent/JP2007517906A/ja not_active Withdrawn
- 2005-01-13 EP EP05711430A patent/EP1708704A4/fr not_active Withdrawn
-
2006
- 2006-07-11 IL IL176791A patent/IL176791A0/en unknown
- 2006-08-11 NO NO20063650A patent/NO20063650L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005069834A3 (fr) | 2006-04-27 |
AR047087A1 (es) | 2006-01-04 |
UA85575C2 (en) | 2009-02-10 |
KR20060125825A (ko) | 2006-12-06 |
CA2552362A1 (fr) | 2005-08-04 |
EA200601315A1 (ru) | 2006-12-29 |
IL176791A0 (en) | 2006-10-31 |
EP1708704A4 (fr) | 2009-08-05 |
MXPA06007660A (es) | 2006-09-04 |
EA011029B1 (ru) | 2008-12-30 |
BRPI0506814A (pt) | 2007-06-05 |
JP2007517906A (ja) | 2007-07-05 |
CN1909904A (zh) | 2007-02-07 |
WO2005069834A2 (fr) | 2005-08-04 |
AU2005206873A1 (en) | 2005-08-04 |
EP1708704A2 (fr) | 2006-10-11 |
US20050154020A1 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053838L (no) | Substituerte alkyl-amido-piperidiner | |
NO20050113L (no) | Sekundaere amino-aniliniske piperidiner som MCH1-antagonister og anvendelser derav | |
NO20050145L (no) | Spirocykliske piperidiner som MCH1-antagonister og anvendelser derav | |
FI109121B (fi) | Menetelmä terapeuttisesti aktiivisten 5-(1-hydroksi-2-piperidinopropyyli)-2-(1H,3H)-indolonianalogien valmistamiseksi | |
JP5139307B2 (ja) | ナトリウムチャネルモジュレーターとしてのプロリンアミド誘導体 | |
JP4597386B2 (ja) | 5−ht6親和性を有するピペリジン−インドール化合物 | |
NO319772B1 (no) | Ligander med hoy affinitet for nociceptinreseptor ORL-1, farmasoytiske preparater inneholdende disse og anvendelse av dem for fremstilling av farmasoytiske preparater. | |
NO20063650L (no) | 4-aryl-piperidiner | |
JP4489940B2 (ja) | 化学的シナプス伝達制御において有用な複素環エーテルおよびチオエーテル化合物 | |
TW201024268A (en) | Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use | |
TW201016700A (en) | Bicyclic heterocycle derivatives and methods of use thereof | |
TW201242961A (en) | FAAH inhibitors | |
EP0654029A1 (fr) | Derives de la piperidine 3-benzylamino-2-phenyle en tant qu'antagonistes des recepteurs de la substance p | |
JP2003530426A (ja) | Pgd2受容体拮抗薬を用いるアレルギー状態の治療のための方法および組成物 | |
EP2549873A1 (fr) | Nouvelles spiro-imidazolones en tant qu'antagonistes de récepteur de glucagon, compositions et leurs procédés d'utilisation | |
BG64196B1 (bg) | 3-пиридил енантиомери и използването им като аналгетици | |
CA2900028C (fr) | Composes substitues de phenylhexahydropyrano[3,4-d][1,3]thiazin-2-amine | |
KR101359852B1 (ko) | 오렉신 길항제로서 피롤리딘-3-일메틸-아민 | |
BRPI0409302A (pt) | derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos | |
KR20180049069A (ko) | 무스카린 m1 수용체 양성 알로스테릭 조절제로서 플루오로인돌 유도체 | |
NO20080411L (no) | Alkylsulfonamiddderivater | |
WO2006041636A3 (fr) | Derives d'aryloxybenzylpiperidine amino-substitues | |
WO2004080411A3 (fr) | Antagonistes du recepteur de l'hormone concentrant la melanine et compositions et methodes associees | |
US20040157822A1 (en) | Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 | |
JP2006526021A5 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |